Biotech · Private company
Oramed, Ltd.
Track this companyFree. Adds Oramed, Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- ORMD-0801Phase 3 · T2DM (Type 2 Diabetes Mellitus)ClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 16 mgPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 8 mgPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 BDPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 QDPhase 3 · Type 2 Diabetes MellitusClinicalTrials.gov · fetched Nov 12, 2026
- Cohort A: ORMD-0801Phase 2 · T2DM (Type 2 Diabetes Mellitus)ClinicalTrials.gov · fetched Nov 12, 2026
- Cohort B: ORMD-0801Phase 2 · T2DM (Type 2 Diabetes Mellitus)ClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801Phase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801Phase 2 · Diabetes Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 (Insulin) capsule 8 mg BDPhase 2 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 Treatment APhase 2 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- ORMD-0801 Treatment BPhase 2 · Type 1 DiabetesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus.PHASE3 · NOT_YET_RECRUITING · started Dec 15, 2025ClinicalTrials.gov NCT06731075 · fetched Nov 12, 2026
- A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusPHASE3 · TERMINATED · started Mar 16, 2021ClinicalTrials.gov NCT04754334 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes MellitusPHASE3 · TERMINATED · started Dec 15, 2020ClinicalTrials.gov NCT04606576 · fetched Nov 12, 2026
- A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)PHASE2 · COMPLETED · started Nov 24, 2020ClinicalTrials.gov NCT04618744 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started Nov 23, 2020ClinicalTrials.gov NCT04564846 · fetched Nov 12, 2026
- A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 DiabetesPHASE2 · COMPLETED · started Oct 17, 2019ClinicalTrials.gov NCT04150107 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started May 29, 2018ClinicalTrials.gov NCT03467932 · fetched Nov 12, 2026
- Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes MellitusPHASE2 · COMPLETED · started Jul 27, 2015ClinicalTrials.gov NCT02496000 · fetched Nov 12, 2026